Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
MDxHealth
company
About
MDxHealth is a molecular diagnostics company that develops epigenetic tests for cancer assessment and personalized treatment of patients.
- 51 - 100
Highlights
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- €9M
- Industries
- Biotechnology,Health Diagnostics,Medical Device
- Founded date
- Jan 1, 2003
- Number Of Employee
- 51 - 100
- Operating Status
- Active
MDxHealth is a molecular diagnostics company that develops and commercializes advanced epigenetic tests for cancer assessment and the personalized treatment of patients.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€9M
MDxHealth has raised a total of
€9M
in funding over 2 rounds. Their latest funding was raised on
Sep 27, 2019 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 27, 2019 | Post-IPO Debt | €9M | 1 |
Kreos Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
MDxHealth is funded by 1 investors.
Kreos Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Kreos Capital
|
Yes | Post-IPO Debt |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
